Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLE-2: Gepotidacin vs Nitrofurantoin for Uncomplicated UTI
NCT04020341Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of gepotidacin in urinary tract infection (UTI), sponsored by GSK. Started Oct 2019; status: completed.
02
Drugs
gepotidacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04020341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020341.